Imunon
IMNN
37 hedge funds and large institutions have $4.14M invested in Imunon in 2021 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 12 reducing their positions, and 5 closing their positions.
554% more call options, than puts
Call options by funds: $85K | Put options by funds: $13K
20% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 5
0% more funds holding
Funds holding: 37 → 37 (0)
0.01% less ownership
Funds ownership: 0.05% → 0.05% (-0.01%)
51% less capital invested
Capital invested by funds: $8.54M → $4.14M (-$4.39M)
67% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 12
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Two Sigma Advisers
New York
|
+$267K |
| 2 |
Two Sigma Investments
New York
|
+$204K |
| 3 |
Renaissance Technologies
New York
|
+$86.5K |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$86.1K |
| 5 |
VF
Virtu Financial
New York
|
+$81K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$1.83M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$53.9K |
| 3 |
Barclays
London,
United Kingdom
|
-$24K |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$24K |
| 5 |
Jane Street
New York
|
-$12.5K |
IMNN Hedge Fund Activity: Q4 2021 in Review
37 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Imunon (IMNN) for Q4 2021, worth a combined $4.14M — down 51% from $8.54M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new IMNN positions and 5 closed out — a net gain of 1 holder — while 4 added to existing stakes and 12 trimmed.
The largest buyer was Two Sigma Advisers, adding an estimated $267K. The largest seller was Morgan Stanley, cutting an estimated $1.83M.
- 37 institutional investors held Imunon (IMNN) as of Q4 2021, unchanged from Q3 2021.
- Funds reported $4.14M of Imunon stock for Q4 2021, down 51% quarter-over-quarter.
- 6 funds opened new Imunon positions in Q4 2021 and 5 closed out, a net change of +1 holder.
- The largest Imunon buyer in Q4 2021 was Two Sigma Advisers, an estimated $267K added.
- The largest Imunon seller in Q4 2021 was Morgan Stanley, an estimated $1.83M sold.
Based on aggregated 13F filings for Q4 2021.